Related Experiment Video
Updated: Jun 29, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Multicenter Development and Prospective Validation of eCARTv5: A Gradient Boosted Machine Learning Early Warning
A new machine learning model, eCART, effectively identifies clinical deterioration in hospitalized patients, outperforming existing scores like NEWS and MEWS. This tool aids in early detection and improves patient outcomes.
Area of Science:
- Clinical informatics
- Machine learning in healthcare
- Patient monitoring
Background:
- Early detection of clinical deterioration is crucial for improving patient outcomes.
- Existing early warning scores often use logistic regression and lack robust validation, especially in subgroups.
- There is a need for advanced machine learning models for accurate and reliable identification of patient decline.
Purpose of the Study:
- To develop and prospectively validate a gradient boosted machine model, eCARTv5, for identifying clinical deterioration in hospitalized patients.
- To compare the performance of eCARTv5 against established scores like MEWS and NEWS.
- To ensure the model's effectiveness across diverse patient demographics and clinical conditions.
Main Methods:
- A multicenter observational study involving retrospective and prospective data from adult inpatient admissions.
- Development and validation using a gradient boosted trees algorithm on demographics, vital signs, documentation, and laboratory values.
- Comparison of eCART with Modified Early Warning Score (MEWS) and National Early Warning Score (NEWS) using Area Under the Receiver Operating Characteristic Curve (AUROC).
Main Results:
- The eCART model demonstrated superior performance in retrospective validation with an AUROC of 0.835, compared to NEWS (0.766) and MEWS (0.704).
- eCART maintained high performance (AUROC ≥0.80) during prospective validation and across various patient subgroups.
- The model accurately predicted intensive care unit transfer or death within 24 hours.
Conclusions:
- The developed eCART model significantly outperformed NEWS and MEWS in both retrospective and prospective validations.
- eCART's consistent performance across diverse patient populations supports its utility in clinical settings.
- These findings paved the way for FDA clearance, enabling eCART's use in identifying deterioration among hospitalized ward patients.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020